NASDAQ:TVTY - Tivity Health Stock Price, Forecast & News

Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."

Tivity Health Inc (NASDAQ:TVTY) issued its quarterly earnings results on Tuesday, November, 12th. The company reported $0.46 earnings per share for the quarter, missing analysts' consensus estimates of $0.56 by $0.10. The company earned $303.90 million during the quarter, compared to the consensus estimate of $301.52 million. Tivity Health had a net margin of 6.41% and a return on equity of 21.67%. Tivity Health's revenue for the quarter was up 100.6% on a year-over-year basis. During the same period last year, the company earned $0.59 earnings per share. View Tivity Health's Earnings History.

Tivity Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Tivity Health.

Tivity Health issued an update on its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided EPS guidance of $2.14-2.32 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.21. The company issued revenue guidance of $$1.127-1.142 billion, compared to the consensus revenue estimate of $$1.13 billion.

10 brokers have issued 12 month price targets for Tivity Health's stock. Their forecasts range from $22.00 to $40.00. On average, they anticipate Tivity Health's share price to reach $29.30 in the next twelve months. This suggests a possible upside of 29.1% from the stock's current price. View Analyst Price Targets for Tivity Health.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tivity Health in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tivity Health.

Press coverage about TVTY stock has trended somewhat negative this week, according to InfoTrie. The research firm ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Tivity Health earned a news sentiment score of -1.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Tivity Health.

Some companies that are related to Tivity Health include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), BioScrip (BIOS), Davita (DVA), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Tivity Health investors own include Energy Transfer LP Unit (ET), CBL & Associates Properties (CBL), Nektar Therapeutics (NKTR), SandRidge Permian Trust (PER), Pfizer (PFE), Cornerstone Total Return Fund (CRF), Canopy Growth (CGC), SunCoke Energy Partners (SXCP), Veeva Systems (VEEV) and Martin Midstream Partners (MMLP).

Tivity Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include Franklin Resources Inc. (3.96%), State Street Corp (3.33%), American Capital Management Inc. (3.29%), Handelsbanken Fonder AB (1.83%), Charles Schwab Investment Management Inc. (1.08%) and Marshall Wace LLP (0.88%). Company insiders that own Tivity Health stock include Bradley S Karro, Donato Tramuto, Ira Sochet and Sara Finley. View Institutional Ownership Trends for Tivity Health.

TVTY stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Marshall Wace North America L.P., Russell Investments Group Ltd., Bank of America Corp DE, SG Americas Securities LLC, Goldman Sachs Group Inc., Snow Capital Management LP and Royce & Associates LP. View Insider Buying and Selling for Tivity Health.

TVTY stock was acquired by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., State of New Jersey Common Pension Fund D, Renaissance Technologies LLC, Handelsbanken Fonder AB, Franklin Resources Inc., Madison Asset Management LLC, State Street Corp and Charles Schwab Investment Management Inc.. Company insiders that have bought Tivity Health stock in the last two years include Bradley S Karro, Ira Sochet and Sara Finley. View Insider Buying and Selling for Tivity Health.

Shares of TVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TVTY stock can currently be purchased for approximately $22.69.

Tivity Health has a market capitalization of $1.09 billion and generates $606.30 million in revenue each year. The company earns $98.80 million in net income (profit) each year or $2.34 on an earnings per share basis. Tivity Health employs 500 workers across the globe.View Additional Information About Tivity Health.

The official website for Tivity Health is http://www.tivityhealth.com/.

Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The company can be reached via phone at 800-869-5311 or via email at [email protected]